Human Milk from Previously COVID-19-Infected Mothers: The Effect of Pasteurization on Specific Antibodies and Neutralization Capacity.
COVID-19
breastfeeding
immunoglobulins
pasteurization
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
13 May 2021
13 May 2021
Historique:
received:
06
04
2021
revised:
02
05
2021
accepted:
11
05
2021
entrez:
2
6
2021
pubmed:
3
6
2021
medline:
9
6
2021
Statut:
epublish
Résumé
Since the outbreak of coronavirus disease 2019 (COVID-19), many put their hopes in the rapid availability of effective immunizations. Human milk, containing antibodies against syndrome coronavirus 2 (SARS-CoV-2), may serve as means of protection through passive immunization. We aimed to determine the presence and pseudovirus neutralization capacity of SARS-CoV-2 specific IgA in human milk of mothers who recovered from COVID-19, and the effect of pasteurization on these antibodies. This prospective case control study included lactating mothers, recovered from (suspected) COVID-19 and healthy controls. Human milk and serum samples were collected. To assess the presence of SARS-CoV-2 antibodies we used multiple complementary assays, namely ELISA with the SARS-CoV-2 spike protein (specific for IgA and IgG), receptor binding domain (RBD) and nucleocapsid (N) protein for IgG in serum, and bridging ELISA with the SARS-CoV-2 RBD and N protein for specific Ig (IgG, IgM and IgA in human milk and serum). To assess the effect of pasteurization, human milk was exposed to Holder (HoP) and High Pressure Pasteurization (HPP). Human milk contained abundant SARS-CoV-2 antibodies in 83% of the proven cases and in 67% of the suspected cases. Unpasteurized milk with and without these antibodies was found to be capable of neutralizing a pseudovirus of SARS-CoV-2 in (97% and 85% of the samples respectively). After pasteurization, total IgA antibody levels were affected by HoP, while SARS-CoV-2 specific antibody levels were affected by HPP. Pseudovirus neutralizing capacity of the human milk samples was only retained with the HPP approach. No correlation was observed between milk antibody levels and neutralization capacity. Human milk from recovered COVID-19-infected mothers contains SARS-CoV-2 specific antibodies which maintained neutralization capacity after HPP. All together this may represent a safe and effective immunization strategy after HPP.
Sections du résumé
BACKGROUND
BACKGROUND
Since the outbreak of coronavirus disease 2019 (COVID-19), many put their hopes in the rapid availability of effective immunizations. Human milk, containing antibodies against syndrome coronavirus 2 (SARS-CoV-2), may serve as means of protection through passive immunization. We aimed to determine the presence and pseudovirus neutralization capacity of SARS-CoV-2 specific IgA in human milk of mothers who recovered from COVID-19, and the effect of pasteurization on these antibodies.
METHODS
METHODS
This prospective case control study included lactating mothers, recovered from (suspected) COVID-19 and healthy controls. Human milk and serum samples were collected. To assess the presence of SARS-CoV-2 antibodies we used multiple complementary assays, namely ELISA with the SARS-CoV-2 spike protein (specific for IgA and IgG), receptor binding domain (RBD) and nucleocapsid (N) protein for IgG in serum, and bridging ELISA with the SARS-CoV-2 RBD and N protein for specific Ig (IgG, IgM and IgA in human milk and serum). To assess the effect of pasteurization, human milk was exposed to Holder (HoP) and High Pressure Pasteurization (HPP).
RESULTS
RESULTS
Human milk contained abundant SARS-CoV-2 antibodies in 83% of the proven cases and in 67% of the suspected cases. Unpasteurized milk with and without these antibodies was found to be capable of neutralizing a pseudovirus of SARS-CoV-2 in (97% and 85% of the samples respectively). After pasteurization, total IgA antibody levels were affected by HoP, while SARS-CoV-2 specific antibody levels were affected by HPP. Pseudovirus neutralizing capacity of the human milk samples was only retained with the HPP approach. No correlation was observed between milk antibody levels and neutralization capacity.
CONCLUSIONS
CONCLUSIONS
Human milk from recovered COVID-19-infected mothers contains SARS-CoV-2 specific antibodies which maintained neutralization capacity after HPP. All together this may represent a safe and effective immunization strategy after HPP.
Identifiants
pubmed: 34068142
pii: nu13051645
doi: 10.3390/nu13051645
pmc: PMC8152997
pii:
doi:
Substances chimiques
Antibodies, Neutralizing
0
Antibodies, Viral
0
Types de publication
Clinical Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Stichting Steun Emma
ID : NA
Références
Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
J Pediatr. 1977 Jan;90(1):29-35
pubmed: 318682
J Food Prot. 2008 Jan;71(1):109-18
pubmed: 18236670
Ann Allergy Asthma Immunol. 1998 Dec;81(6):523-33; quiz 533-4, 537
pubmed: 9892025
Int J Food Microbiol. 2020 Jul 16;325:108629
pubmed: 32325344
Lancet. 2020 Jun 6;395(10239):1751-1752
pubmed: 32505245
J Virol. 2004 Jan;78(2):947-57
pubmed: 14694126
Sci Transl Med. 2021 Jan 20;13(577):
pubmed: 33288662
J Pediatr Gastroenterol Nutr. 2009 Jul;49(1):112-25
pubmed: 19502997
Food Chem. 2014 May 15;151:79-85
pubmed: 24423505
Signal Transduct Target Ther. 2020 Nov 24;5(1):275
pubmed: 33235188
J Matern Fetal Neonatal Med. 2010 Sep;23 Suppl 2:1-20
pubmed: 20840052
Nutrients. 2019 Apr 24;11(4):
pubmed: 31022910
J Exp Med. 2020 Nov 2;217(11):
pubmed: 32692348
Vaccine. 2003 Jul 28;21(24):3374-6
pubmed: 12850343
PLoS One. 2013 Aug 14;8(8):e70867
pubmed: 23967126
Acta Pharm Sin B. 2020 Jul;10(7):1228-1238
pubmed: 32363136
Nutrients. 2019 May 24;11(5):
pubmed: 31137691
Nutrients. 2016 Aug 02;8(8):
pubmed: 27490567
J Immunol. 2020 Dec 15;205(12):3491-3499
pubmed: 33127820
Lancet Child Adolesc Health. 2020 May;4(5):355
pubmed: 32246910
Pediatrics. 2006 Feb;117(2):425-32
pubmed: 16452362
Nutrients. 2019 Jul 11;11(7):
pubmed: 31336756
Science. 2020 Aug 7;369(6504):643-650
pubmed: 32540902
Mucosal Immunol. 2011 Nov;4(6):603-11
pubmed: 21975936
iScience. 2020 Nov 20;23(11):101735
pubmed: 33134887